A RANDOMIZED, PARALLEL, SINGLE-CENTER, DOUBLE-MASKED, VEHICLE-CONTROLLED PHASE II STUDY TO EVALUATE THE ACTIVITY OF NS2 OPHTHALMIC SOLUTION IN SUBJECTS WITH ALLERGIC CONJUNCTIVITIS USING THE CONJUNCTIVAL ALLERGEN PROVOCATION TEST (CAPT)

Registry ID

ALDNS2-203-D1 (15-MO-001)

Source registry

HEALTH_CANADA

Status

Ongoing

Phase

PHASE2

Study type

INTERVENTIONAL

Sponsor

ALDEYRA THERAPEUTICS INC

Start date

2015-08-28

Last update

2015-08-24

Conditions

• ALLERGIC CONJUNCTIVITIS

View on source registry